Evidence map›Paper›PMID 31872321›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2019

Discovery of metabolic alterations in the serum of patients infected with Plasmodium spp. by high-resolution metabolomics.

Jinhyuk Na, Adnan Khan, Jae Kwan Kim, Abdul Wadood, Young Lan Choe, Douglas I Walker, Dean P Jones, Chae Seung Lim, Youngja Hwang Park

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Application of a Non-Targeted Metabolomics Study inInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Plasma metabolites in childhood Burkitt lymphoma cases and cancer-free controls in Uganda.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Multi-Omics Advancements towardsDiagnostics (Basel, Switzerland) · 2021
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Jinhyuk NaCollege of Pharmacy, Korea University, 2511 Sejong-ro, Jochiwon-eup, Sejong, 30019, Republic of Korea.
Adnan KhanCollege of Pharmacy, Korea University, 2511 Sejong-ro, Jochiwon-eup, Sejong, 30019, Republic of Korea.
Jae Kwan KimCollege of Pharmacy, Korea University, 2511 Sejong-ro, Jochiwon-eup, Sejong, 30019, Republic of Korea.
Abdul WadoodCollege of Pharmacy, Korea University, 2511 Sejong-ro, Jochiwon-eup, Sejong, 30019, Republic of Korea.
Young Lan ChoeDepartment of Laboratory Medicine, Korea University Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.
Douglas I WalkerClinical Biomarkers Laboratory, Department of Medicine, Emory University, Atlanta, GA, 30308, USA.
Dean P JonesClinical Biomarkers Laboratory, Department of Medicine, Emory University, Atlanta, GA, 30308, USA.
Chae Seung LimDepartment of Laboratory Medicine, Korea University Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea. malarim@korea.ac.kr.
Youngja Hwang ParkCollege of Pharmacy, Korea University, 2511 Sejong-ro, Jochiwon-eup, Sejong, 30019, Republic of Korea. yjhwang@korea.ac.kr.ORCID 0000-0003-4348-2217
Korea University · KREmory University · USKorea University Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDespite the advances in diagnosis and treatment, malaria has still not been eradicated. Metabolic interactions between the host and Plasmodium may present novel targets for malaria control, but such interactions are yet to be deciphered. An exploration of metabolic interactions between humans and two Plasmodium species by high-resolution metabolomics may provide fundamental insights that can aid the development of a new strategy for the control of malaria.

objectivesThis study aimed at exploring the metabolic changes in the sera of patients infected with Plasmodium falciparum and Plasmodium vivax.

methodsUni- and multivariate metabolomic analyses were performed on the sera of four groups of patients, namely normal control (N, n = 100), P. falciparum-infected patients (PF, n = 21), P. vivax-infected patients (PV, n = 74), and non-malarial pyretic patients (Pyr, n = 25).

resultsUnivariate and multivariate analyses of N, PF, and PV groups showed differential metabolic phenotypes and subsequent comparisons in pairs revealed significant features. Pathway enrichment test with significant features showed the affected pathways, namely glycolysis/gluconeogenesis for PF and retinol metabolism for PV. The metabolites belonging to the affected pathways included significantly low 2,3-diphosphoglycerate and glyceraldehyde-3-phosphate in the sera of PF. The sera of PV had significantly low levels of retinol but high levels of retinoic acid.

conclusionOur study reveals metabolic alterations induced by Plasmodium spp. in human serum and would serve as a milestone in the development of novel anti-malarial strategies.

Indexed as

Metabolomics2,3-DiphosphoglycerateAdultAgedBiomarkersCase-Control StudiesCluster AnalysisDiscriminant AnalysisFemaleGlyceraldehyde 3-PhosphateHumansMalariaMaleMiddle AgedPlasmodium falciparumPlasmodium vivax2,3-DiphosphoglycerateBiomarkersGlyceraldehyde 3-PhosphateTretinoinVitamin ABiomarkerLC–MSMalariaMetabolomicsPlasmodium falciparumPlasmodium vivax

Identifiers

PMID31872321
OpenAlexW2996124890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.